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Primers and a TaqMan probe for the 5-untranslated region (UTR) of the hepatitis A virus (HAV) genome
were designed and evaluated. The assay detected 0.5 infectious units of HAV and 40 copies of a synthetic
transcript and provides an important screening tool for rapid quantitative HAV detection in clinical or
environmental samples.
Hepatitis A virus (HAV) is the major cause of acute hepa-
titis in developed countries (27), while in developing countries
infection is endemic. Person-to-person contact is the most
common mode of transmission, and because HAV is transmit-
ted by the fecal-oral route, improved hygiene and sanitation
levels can reduce endemicity (1, 28, 30). In the United States,
48% of reported cases are of unknown origin (12), and con-
taminated food or water have been identified as a risk factor in
only 4%. Currently, it is not known whether contaminated food
or water is the source of infection for some of the cases with
unknown origin (12). Contaminated food or water is usually
recognized as a source when a cluster of infections occur (8, 10,
11, 13, 14, 21, 26).
HAV is a member of the genus Hepatovirus, which belongs
to the family Picornaviridae (19). The nonenveloped virion
contains a 7.5-kb positive-stranded RNA containing one open
reading frame (ORF) of about 6,500 nucleotides. The genome
is composed of five functional regions, the 5-untranslated re-
gion (5UTR), three regions that encode viral polypeptides
(P1, P2, and P3), and the 3-untranslated region (3UTR). The
5UTR is approximately 600 nucleotides in length and is the
most conserved region of the genome and therefore is the most
suitable region for design of primers that would detect most
genotypes.
Although only one human serotype has been observed world-
wide, HAV can be classified into six genotypes based upon
differences in the 168-nucleotide sequence between 3024 and
3191 in the VP1-P2 region (17, 25). This more variable region
has been used to distinguish genotypes. Genotypes I, II, and III
were found in humans, while genotypes IV, V, and VI were
recovered from simians (17, 20, 23, 29). Early investigations
identified a seventh genotype (25), but recent analysis of the
complete capsid genome region and complete genomes of ad-
ditional isolates has indicated that genotype VII should be
reclassified as genotype IIB (4, 17). Genotype I and III are
each further classified into subtypes IA, IB, IIIA, and IIIB.
Based on existing information, Genotype I is the most common
worldwide and Genotype 1A is more common than IB.
This report demonstrates the development and application
of TaqMan real-time reverse transcription-PCR (RT-PCR) for
the rapid detection of all human genotypes of HAV using
highly conserved sequences within the 5UTR. Two previous
reports that describe real-time HAV assays used different
primers and probes than those we have employed (5, 22). One
of these assays required two reverse primers to theoretically
detect all genotypes and reported a sensitivity of five RNA
copies (5); the other assay used only one of the reverse primers
and the same forward primer and probe as the first report, but
it was not as sensitive as the first assay (22). A sensitive assay
that can detect all human genotypes is needed. The investiga-
tion of outbreaks that may cross national and continental
boundaries requires assays that will rapidly detect all genotypes
of HAV in the clinical or environmental samples available for
investigation by public health officials. In addition, routine
testing should also be performed with a rapid, sensitive test
that can detect all human genotypes.
The cell culture adapted cytopathic variant clone 24A HM-
175 (6), a representative HAV genotype IB, was used to es-
tablish the sensitivity of the TaqMan assay for infectious virus.
Virus propagation, purification, and plaque assay were per-
formed as previously described (6), and a passage level 4 virus
stock with titer of 2  107 PFU/ml was used in the experiments.
Genotype IB RNA was extracted from this preparation. Wild-
type genotype IA HAV RNA was obtained from a 20% stool
preparation from a chimpanzee inoculated with a human wild-
type virus (18). The genotype IIIA RNA was obtained from a
human stool preparation (16). Prior to RNA extraction, the
stool preparation was extracted with an equal volume of chlo-
roform, and RNA was extracted from the aqueous fraction.
Genotype VII (or IIB) RNA was obtained from a liver prep-
aration stored at 70°C as previously described (3). The RNA
from the representative IIA genotype was extracted from cell
culture grown CF53/Berne (17). Viral RNA was extracted
from preparations of each genotype or from serial 10-fold
dilutions of the preparations using the QIAamp viral RNA
mini-kit (QIAGEN, Valencia, CA) following the manufactur-
er’s instructions. The extracted RNA was resuspended in Tris-
EDTA buffer and used immediately in the assay. In addition to
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these prototypes of each human HAV genotype, HAV-positive
stool samples from two separate outbreaks were analyzed.
Seven samples obtained during a well water outbreak (8) and
three samples from a community-wide outbreak (24) were
tested. All of these samples were previously characterized as
genotype IA, the genotype most often found in North America.
RNA was extracted from these outbreak samples (20% stool
preparations) with the QIAamp MinElute Virus Spin kit using
the manufacturers instructions (QIAGEN, Valencia, CA). Ta-
ble 1 provides a summary of all the isolates tested.
The 5UTR primers and TaqMan probe chosen for detec-
tion of HAV are shown in Fig. 1. The TaqMan probe was
labeled with 6-carobxy-fluorescein (FAM) at the 5 and a with
a black hole quencher (BHQ) at the 3. Real-time RT-PCR
was performed in the LightCycler (Roche, Indianapolis, IN)
glass reaction capillaries containing sample RNA (2 l each) in
a 20-l volume with 0.25 M primers and 150 nM flourogenic
probe. Nucleotides, reverse transcriptase, Taq DNA polymer-
ase, and buffer were included in the QuantiTectTm Probe
RT-PCR kit (QIAGEN, Valencia, CA). A typical protocol
took approximately 90 min to complete. After a 30-min reverse
transcription reaction and a hot-start denaturation step of 15
min, 45 cycles of 95°C for 10 s, 55°C for 20 s, and 72°C for 15 s
were completed. The fluorescence was measured at the end of
each annealing step. All amplifications reactions were carried
out in duplicate. To confirm the correct amplicon size, prod-
ucts from each primer pair were subjected to agarose gel elec-
trophoresis.
Synthetic RNA was synthesized in a two-step process: (i) the
RT-PCR product of HM-175 24A (generated with primers
described in Fig. 1) was ligated to T7 phage RNA polymerase
promoter; (ii) PCR amplification was performed to generate a
transcription template from which a large quantity of synthetic
transcripts was made.
The PCR product from HAV (HM175-24A) was purified
with a PCR purification kit (QIAGEN, Valencia, CA) and
ligated with the T7 bacteriophage promoter as described in the
manufacturers protocol (Ambion Inc., Austin, TX). The re-
sulting mixture was used immediately in the Lig’nScribe PCR
with the forward primer from Ambion and the reverse HAV
primer (Fig. 1). The resulting fragment was transcribed in vitro
with T7 RNA polymerase (T7 MEGAshortscript high yield
transcription kit; Ambion) to yield high quantities of HAV
RNA transcripts. RNA concentration was 2  1011 RNA cop-
ies/ml. Serial 10-fold dilutions of HAV RNA were prepared in
Tris-EDTA containing 1.0 U of RNasin plus RNase inhibi-
tor/l (Promega, Madison, WI) and 100 ng/l of yeast tRNA
(Ambion, Austin, TX) from the starting concentration of 108
copies/ml and assayed by the TaqMan assay.
Prototype isolates representing HAV genotypes IA, IB, IIA,
IIB, and IIIA were detected with the real-time TaqMan assay
as shown in Fig. 2. RNA extracted from each genotype prep-
aration was assayed as described above. HAV was detected in
all preparations by 25 cycles as shown on the X axis. Samples
of genotype IIA and IIB (or VII) showed a lower plateau than
the other genotypes, which is likely explained by the two mis-
matches in the probe for this genotype (Fig. 1). However, the
cycle number of detection was very low, 17 and 19 cycles,
respectively, indicating good sensitivity (Fig. 2). Amplification
using our primers in the presence of syber green (which mea-
sures double-stranded DNA) revealed that equivalent ampli-
fication was obtained for all the human genotypes (data not
shown). Comparison of the one sequence available (genotype
V) of the simian genotypes demonstrated two mismatches in
the reverse primer and six mismatches in the probe, indicating
that the assay is very unlikely to detect this virus (Fig. 1). Other
simian virus sequences are not available for comparison and
therefore may not be excluded from detection at this time. The
primers and probe did not react with human hepatitis E virus
(HEV), swine HEV, or several human enteroviruses in labo-
ratory trials.
Quantitative evaluation of the assay for detection of the
HM-175 stock and synthetic RNA is shown in Fig. 3. Detection
is linear over five log10 dilutions, and the most dilute sample
(with an intercept at 36 cycles) represents detection of 0.5 PFU
24A HM175 HAV (Fig. 3A). A comparison of threshold cycle
versus log10 copy number of synthetic HAV RNA is shown in
Fig. 3B. The estimated starting copy number was 2  108
molecules/ml as measured by optical density at A260/A280 nm,
and the sensitivity of the assay was at least 40 HAV copies/
reaction (2  104 copies/ml). Four copies per reaction yielded
a negative test.
FIG. 1. Sequence alignment of HAV genotypes in the amplified region. The actual sequence of the reverse primer is 5AACAACTCACCA
ATATCCGC3. GenBank sequence numbers are indicated.
TABLE 1. Description of isolates evaluated with TaqMan assaya
Virus sample Source Genotype Reference
HLD-2 CDC IA 18
HM-175, clone 24A CDC IB 6
CF-53 CDC IIA 17
Sierra Leonne CDC IIB 3
GA-76 CDC IIIA 16
Quebec outbreak (7 samples) CDC IA 8
Stanislaus County, CA (3 samples) CDC IA 24
a All samples were positive by real-time RT-PCR. CDC, Centers for Disease
Control and Prevention.
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In addition to the assay of undiluted preparations of each
genotype shown in Fig. 2, assay of a 10-fold dilution series of
each genotype was performed with the real-time assay (Table
2). Only the genotype IB sample (assayed for infectivity in cell
culture) was assayed quantitatively for comparison in the real-
time assay. Other isolates tested do not have any quantitative
measurement, such as the plaque assay, for comparison with
real-time detection in RT-PCR. The average results of two
FIG. 2. Detection of human HAV genotypes with the 5UTR TaqMan RT-PCR assay.
FIG. 3. Standard calibration curve for the HAV real-time RT-PCR assay. (A) The range of detection of Genotype IB (clone 24A HM-175).
(B) Detection over a linear range of synthetic HAV RNA. The log of the initial template PFU (A) or copy number (B) is plotted horizontally,
and the cycle number plotted at the crossing point is plotted vertically.
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separate experiments analyzing 10-fold dilution series for each
genotype are shown in Table 2. Using the LightCycler soft-
ware, the slope and regression values were calculated based on
the data obtained for five to seven serial log10 dilutions of each
genotype sample from which RNA was extracted. The effi-
ciency for each genotype was calculated with the formula de-
scribed. The results of these experiments demonstrate good
performance of the assay for detection of all tested genotypes
over a significant range of concentrations (five to seven orders
of magnitude).
The developed assay is highly reproducible over a wide
range of dilutions for all human HAV genotypes. Detection of
all human HAV genotypes is important in the evaluation of
potential outbreaks or environmental contamination. The cur-
rent practice of shipping food worldwide and international
travel make it important to be able to rapidly detect all geno-
types, including those that may not commonly occur in North
America. There are several advantages of the TaqMan assay
for detection of HAV in environmental or clinical samples
including: (i) detection within 2 h in comparison to 1 or 2 days
for confirmed standard RT-PCR detection; (ii) the real-time
PCR assay is carried out in a closed tube format, substantially
decreasing any opportunity for false positive results; (iii) spec-
ificity is equal to or greater than other hybridization assays or
a second round of PCR, because the highly specific probe
hybridizes in the central portion of the amplicon. The quanti-
tative potential of the TaqMan assay is also important. The
number of RNA copies in a specimen can be estimated by
comparison with the standard curve and cycle numbers within
the same reaction.
Based upon published reports for the ratio of physical par-
ticles to infectious particles for cytopathic HM-175 (58:1 to
79:1) (9, 15), the sensitivity of detection of HAV RNA (40
copies) is similar to the sensitivity of detection of infectious
HM-175 (0.5 PFU). The sensitivity of the real-time assay was
similar or better than standard RT-PCR followed by nested
PCR or hybridization if volumes of RNA per reaction are
considered (2). Furthermore, with the different real-time PCR
platform machines that are now available, a larger volume may
easily be evaluated to achieve even greater sensitivity.
HAV is very difficult, if not impossible, to culture from
clinical and environmental samples, and therefore molecular
detection is a very important analytical tool. Culture of wild-
type virus requires a larger quantity of virus than is commonly
found in environmental sample concentrates or requires many
months of serial cell culture passage to grow the low quantity
of virus present in these samples (7). Evaluation of the assay
for detection of HAV in spiked water and food samples is in
progress. Use of the TaqMan assay will provide a rapid meth-
od for detection of HAV in food, water or clinical speci-
mens.
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